Doxycycline in Therapy of Erythema Migrans

• Status: Completed
• Trial end date: 2014-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators will compare the outcome of three groups of erythema migrans patients treated with doxycycline: a group without any accompanying symptoms, with mild symptoms and with severe symptoms that require lumbar puncture.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Medical Centre Ljubljana
• Treatments: Doxycycline

Criteria

Inclusion Criteria:

• presence of erythema migrans

• >15 years old

• informed consent

Exclusion Criteria:

• pregnancy

• lactation

• multiple erythema migrans

• already treated with antibiotic for this episode of Lyme borreliosis

• allergy to doxycycline

• treatment with drugs with known interactions with doxycycline

• cerebrospinal fluid pleocytosis